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artery disease may occur with an increased consumption of fruc-
tose (3). The conclusion by Elliott et al that dietary fructose has
only detrimental metabolic and endocrine effects is somewhat
misleading. However, Elliott et al do suggest that much more
research is needed to fully understand the metabolic effects of
dietary fructose, particularly in humans.
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Reply to TJ Vasankari 
Dear Sir:
We agree with Vasankari that dietary fat and inactivity are likely
environmental factors contributing to the marked worldwide
increase in the prevalence of obesity, and this was noted in our
review on the metabolic effects of fructose (1). However, we
believe that an increase in fructose consumption also deserves
attention as a potential third factor contributing to the escalation of
obesity. Because we are not aware of quantitative data regarding
the relative contributions of the 3 factors, we consider it prema-
ture to conclude that dietary fat and reduced physical activity are
“much more probable contributors” to the obesity epidemic. As
we and Bray (2) have pointed out, fructose consumption has
increased concurrently with the obesity epidemic. Furthermore,
because fructose—similarly to dietary fat—does not stimulate
insulin secretion, leads to decreased leptin production, and does
not suppress the orexigenic gastric hormone ghrelin (3), the lack
of effects of long-term fructose consumption on these endocrine
systems involved in the regulation of energy homeostasis could
lead to increased energy intake, weight gain, and obesity. We there-
fore regard increased fructose consumption to be a likely contrib-
utor to the increased prevalence of obesity in the past 2–3 decades.
Vasankari discusses the inclusion of fructose in the diets of
patients with diabetes because of its low glycemic index. In our
review we briefly addressed this topic and also cited evidence
that the consumption of small catalytic amounts of fructose
increases hepatic glucose uptake and reduces glucose excur-
sions after treatment with oral glucose in subjects with type 2
diabetes (1). Thus, we agree that modest amounts of dietary fruc-
tose may be beneficial in the dietary management of diabetes.
Although we intentionally did not provide an in-depth discus-
sion of or cite additional literature on studies of fructose con-
sumption in diabetes, we believe that certain issues should be
considered before high-fructose diets are recommended for dia-
betic patients. First, when large amounts of fructose are rapidly
consumed, a sufficient amount of fructose may escape hepatic
uptake to significantly elevate systemic circulating fructose
concentrations. Protein fructosylation could contribute to dia-
betic complications (4), particularly because fructose is a major
product of the polyol-sorbitol pathway and because tissue fruc-
tose accumulation has been implicated in diabetic neuropathy
and other complications of diabetes. It was reported that con-
sumption of a high-fructose diet increases both the formation
of cataracts and of oxidative byproducts in the kidneys of strep-
tozotocin-diabetic rats (5). In nondiabetic rats, fructose con-
sumption for 1 y led to increased glycation (fructosamine and
glycated hemoglobin) and markers of lipid peroxidation and
aging when compared with animals that consumed glucose (6).
The effect of dietary fructose on glycation and oxidation-related
products deserves further investigation, and it is important to
determine whether increased glycation and oxidation occur in
humans consuming high amounts of dietary fructose.
In addition, although not all studies have shown an adverse
effect of fructose consumption on lipids, several studies (7–9),
including our own (3), showed that—compared with glucose—
fructose increases postprandial triacylglycerol. Although this
effect is likely to be highly dependent on the amount of fructose
consumed, evidence exists that fructose-induced hypertriglyc-
eridemia is magnified in subjects with insulin resistance (10) or
hypertriglyceridemia (6, 11). Therefore, caution should be exer-
cised when recommending diets high in fructose to patients with
the metabolic syndrome or type 2 diabetes. Furthermore, in pre-
liminary studies, we found that overweight women with normal
fasting triacylglycerol concentrations who consumed 25% of
energy from fructose-sweetened beverages for 10 wk had
markedly increased postprandial triacylglycerol concentrations
(compared with a baseline diet high in complex carbohydrate) and
significantly elevated concentrations of atherogenic apolipopro-
tein B (12). In contrast, postprandial triacylglycerol and
apolipoprotein B concentrations did not increase in subjects who
consumed 25% of energy as glucose, which induced larger post-
prandial circulating glucose and insulin excursions than did the
consumption of complex carbohydrate or fructose. Thus, the con-
sumption of glucose-sweetened beverages—which have a high
glycemic index—does not result in adverse changes in the post-
prandial lipid profile.
In summary, the effects of fructose on postprandial triacylglycerol
and apolipoprotein B concentrations suggest that long-term consump-
tion of high amounts of fructose could contribute to the risk of cardio-
vascular disease. As indicated by some studies, this effect is likely to
be exacerbated in subjects with preexisting metabolic disease. Finally,
as discussed above, the lack of effects on endocrine systems involved
in body weight regulation suggests that the long-term consumption of
diets high in fructose may lead to weight gain, obesity, and the devel-
opment of type 2 diabetes. Clearly, much additional research is needed
to more fully understand the metabolic effects of high-fructose diets,
particularly in subjects at risk of metabolic diseases, ie, obese, insulin-
resistant, or hyperlipidemic persons. Limiting fructose consumption
may be a desirable objective in the management of obesity and hyper-
lipidemia in individual persons and in the prevention of weight gain
and its metabolic consequences at the population level.
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Erratum
Francois CA, Connor SL, Bolewicz LC, Connor WE. Supplementing lactating women with flaxseed oil does not increase
docosahexaenoic acid in their milk. Am J Clin Nutr 2003;77:226–33.
In Table 1 on page 227, the values for fatty acids 18:1n9 and 20:1n9 were interchanged. The value for 18:1n9 should
read 20.5% by wt of total fatty acids, and the value for 20:1n9 should read 0.0% by wt of total fatty acids.
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